122 related articles for article (PubMed ID: 14751509)
1. Tumor-line specific pO(2) fluctuations in human melanoma xenografts.
Brurberg KG; Graff BA; Olsen DR; Rofstad EK
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):403-9. PubMed ID: 14751509
[TBL] [Abstract][Full Text] [Related]
2. pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
Ellingsen C; Ovrebø KM; Galappathi K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1317-23. PubMed ID: 22270159
[TBL] [Abstract][Full Text] [Related]
3. Temporal heterogeneity in oxygen tension in human melanoma xenografts.
Brurberg KG; Graff BA; Rofstad EK
Br J Cancer; 2003 Jul; 89(2):350-6. PubMed ID: 12865929
[TBL] [Abstract][Full Text] [Related]
4. Fluctuations in pO2 in irradiated human melanoma xenografts.
Brurberg KG; Thuen M; Ruud EB; Rofstad EK
Radiat Res; 2006 Jan; 165(1):16-25. PubMed ID: 16392958
[TBL] [Abstract][Full Text] [Related]
5. Measurements of tumor tissue oxygen tension using a time-resolved luminescence-based optical oxylite probe: comparison with a paired survival assay.
Urano M; Chen Y; Humm J; Koutcher JA; Zanzonico P; Ling C
Radiat Res; 2002 Aug; 158(2):167-73. PubMed ID: 12105986
[TBL] [Abstract][Full Text] [Related]
6. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours.
Rofstad EK; Måseide K
Int J Radiat Biol; 1999 Nov; 75(11):1377-93. PubMed ID: 10597912
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Helzel and OxyLite systems in the measurements of tumor partial oxygen pressure (pO2).
Wen B; Urano M; Humm JL; Seshan VE; Li GC; Ling CC
Radiat Res; 2008 Jan; 169(1):67-75. PubMed ID: 18159950
[TBL] [Abstract][Full Text] [Related]
8. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis.
Rofstad EK; Galappathi K; Mathiesen B; Ruud EB
Clin Cancer Res; 2007 Apr; 13(7):1971-8. PubMed ID: 17360973
[TBL] [Abstract][Full Text] [Related]
9. An integrated approach to measuring tumor oxygen status using human melanoma xenografts as a model.
Menon C; Polin GM; Prabakaran I; Hsi A; Cheung C; Culver JP; Pingpank JF; Sehgal CS; Yodh AG; Buerk DG; Fraker DL
Cancer Res; 2003 Nov; 63(21):7232-40. PubMed ID: 14612518
[TBL] [Abstract][Full Text] [Related]
10. Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice.
Yasui H; Matsumoto S; Devasahayam N; Munasinghe JP; Choudhuri R; Saito K; Subramanian S; Mitchell JB; Krishna MC
Cancer Res; 2010 Aug; 70(16):6427-36. PubMed ID: 20647318
[TBL] [Abstract][Full Text] [Related]
11. Interstitial fluid pressure and capillary diameter distribution in human melanoma xenografts.
Tufto I; Rofstad EK
Microvasc Res; 1999 Nov; 58(3):205-14. PubMed ID: 10527764
[TBL] [Abstract][Full Text] [Related]
12. Detection of different hypoxic cell subpopulations in human melanoma xenografts by pimonidazole immunohistochemistry.
Gulliksrud K; Vestvik IK; Galappathi K; Mathiesen B; Rofstad EK
Radiat Res; 2008 Nov; 170(5):638-50. PubMed ID: 18959463
[TBL] [Abstract][Full Text] [Related]
13. Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts.
Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
J Transl Med; 2017 Nov; 15(1):241. PubMed ID: 29183378
[TBL] [Abstract][Full Text] [Related]
14. Optical sensor-based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft lines.
Bussink J; Kaanders JH; Strik AM; Vojnovic B; van Der Kogel AJ
Radiat Res; 2000 Nov; 154(5):547-55. PubMed ID: 11025651
[TBL] [Abstract][Full Text] [Related]
15. Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia.
Blumenthal RD; Taylor A; Osorio L; Ochakovskaya R; Raleigh JA; Papadopoulou M; Bloomer WD; Goldenberg DM
Int J Cancer; 2001 Nov; 94(4):564-71. PubMed ID: 11745445
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
17. Fraction of radiobiologically hypoxic cells in human melanoma xenografts measured by using single-cell survival, tumour growth delay and local tumour control as end points.
Rofstad EK; Måseide K
Br J Cancer; 1998 Oct; 78(7):893-8. PubMed ID: 9764580
[TBL] [Abstract][Full Text] [Related]
18. Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors.
Cairns RA; Kalliomaki T; Hill RP
Cancer Res; 2001 Dec; 61(24):8903-8. PubMed ID: 11751415
[TBL] [Abstract][Full Text] [Related]
19. Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination.
Rofstad EK; Gaustad JV; Egeland TA; Mathiesen B; Galappathi K
Int J Cancer; 2010 Oct; 127(7):1535-46. PubMed ID: 20091868
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
